Tag Archives: PHARMAC
Pharmac reverses controversial brand switch decision
Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading
PHARMAC prepares to take over the procurement of medical devices
Access to medical devices in New Zealand is changing The Therapeutic Products Bill will be published shortly, resulting in PHARMAC assuming responsibility for the procurement and funding of medical devices in addition to their current brief of medicines. This … Continue reading
PHARMAC issues a call for funding applications for medicines for rare disorders
Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019. Eligibility criteria: The medicine must have been approved … Continue reading
Defining value in the MBS Review
In May 2015 the Federal Government announced a review of the Medicare Benefits Schedule (MBS) with a view to bringing the MBS up-to-date and increase the value derived from the more than 5,700 listed items. The announcement of this review … Continue reading
Commercial Eyes joins Medicines New Zealand
While Commercial Eyes has been providing a full range of services to our clients across the Tasman for a number of years we have now highlighted our commitment to New Zealand by recently joining Medicines New Zealand. Two of our … Continue reading
PHARMAC: The more things change…
Following an internal review and extensive community consultation process, New Zealand’s Pharmaceutical Management Agency (PHARMAC) is changing the way it makes decisions about the funding of medicines and medical devices. The overarching objective of PHARMAC will remain “to secure for … Continue reading
